Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Rapaport

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
CNS Spectrums|February 24, 2004
Quality of life in geriatric patients with mood and anxiety disordersRachel E Maddux, Katia K Delrahim, Mark H Rapaport
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 19, 2012
Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studiesBrian J Miller, Nickolas Culpepper, Mark H Rapaport, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Validation of the Scale of Functioning in Older Outpatients With SchizophreniaMark H Rapaport, James Bazzetta, Lou Ann McAdams, et al.
Innovations in Clinical Neuroscience|October 20, 2011
Attitude toward humor in patients experiencing depressive symptomsAnna Bokarius, Khanh Ha, Russell Poland, et al.
Neuroendocrinology|October 14, 2021
Locus Coeruleus Noradrenergic Modulation of Diurnal Corticosterone, Stress Reactivity, and Cardiovascular Homeostasis in Male RatsK V Thrivikraman, Becky Kinkead, Michael J Owens, et al.
Sleep|November 9, 2018
Insomnia and suicidal ideation in nonaffective psychosisBrian J Miller, Carmen B Parker, Mark H Rapaport, et al.
Frontiers in Neurology|April 21, 2017
Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the FutureKaren S Rommelfanger, Stewart A Factor, Suzette LaRoche, et al.
Frontiers in Psychiatry|August 4, 2025
A heterotrimeric G protein (Gsα) biomarker may predict antidepressant response in subjects with major depressive disorderSteven D Targum, Aksu Gunay, Alex Leow, et al.
Schizophrenia Research|September 18, 2004
Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scoresLeslie A Lenert, Ann P Sturley, Mark H Rapaport, et al.
Molecular Psychiatry|December 31, 2021
A novel peripheral biomarker for depression and antidepressant responseSteven D Targum, Jeffrey Schappi, Athanasia Koutsouris, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
CNS Spectrums|February 24, 2004
Quality of life in geriatric patients with mood and anxiety disordersRachel E Maddux, Katia K Delrahim, Mark H Rapaport
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 19, 2012
Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studiesBrian J Miller, Nickolas Culpepper, Mark H Rapaport, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 23, 2017
Validation of the Scale of Functioning in Older Outpatients With SchizophreniaMark H Rapaport, James Bazzetta, Lou Ann McAdams, et al.
Innovations in Clinical Neuroscience|October 20, 2011
Attitude toward humor in patients experiencing depressive symptomsAnna Bokarius, Khanh Ha, Russell Poland, et al.
Neuroendocrinology|October 14, 2021
Locus Coeruleus Noradrenergic Modulation of Diurnal Corticosterone, Stress Reactivity, and Cardiovascular Homeostasis in Male RatsK V Thrivikraman, Becky Kinkead, Michael J Owens, et al.
Sleep|November 9, 2018
Insomnia and suicidal ideation in nonaffective psychosisBrian J Miller, Carmen B Parker, Mark H Rapaport, et al.
Frontiers in Neurology|April 21, 2017
Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the FutureKaren S Rommelfanger, Stewart A Factor, Suzette LaRoche, et al.
Frontiers in Psychiatry|August 4, 2025
A heterotrimeric G protein (Gsα) biomarker may predict antidepressant response in subjects with major depressive disorderSteven D Targum, Aksu Gunay, Alex Leow, et al.
Schizophrenia Research|September 18, 2004
Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scoresLeslie A Lenert, Ann P Sturley, Mark H Rapaport, et al.
Molecular Psychiatry|December 31, 2021
A novel peripheral biomarker for depression and antidepressant responseSteven D Targum, Jeffrey Schappi, Athanasia Koutsouris, et al.
Pageof 6